Velcade (Bortezomib), Adriamycin Dexamethasone (PAD) or Vincristine Adriamycin Dexamethasone in Second Line Treatment of Multiple Myeloma

Stopped TRIAL STOPPED due to a change in standard of care and the required patient numbers could no longer be achieved

Conditions

• Multiple Myeloma

Interventions

• DRUG: adriamycin
• DRUG: bortezomib
• DRUG: dexamethasone
• DRUG: vincristine

Sponsor

Janssen-Cilag International NV